Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 64% · prior close shown (market closed)
Outlook Therapeutics, Inc. execution reads as mixed on proprietary earnings and initiative evidence.
4 signals not yet derived from pipeline evidence
Pipeline evidence · 1d ago
Reported figures for Outlook Therapeutics, Inc. — research only, not investment advice.
Updated
What happened recently for Outlook Therapeutics, Inc. (OTLK) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$0.76
Market cap
$91.42M
Profitable
No
Revenue $1.41M
Net income
$-62.42M
FY Sep 30, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Outlook Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Outlook Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.